+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neurovascular Intervention Market by Devices, by Application, by Region, Market Outlook 2027

  • ID: 5119032
  • Report
  • June 2020
  • Region: Global
  • 110 Pages
  • Rockville Research

FEATURED COMPANIES

  • Medtronic Plc
  • Penumbra Inc.
  • Stryker Corporation
  • Terumo Corporation

Industry Insights

According to this new report, the global neurovascular intervention market is estimated to be valued at US$ 4.5 billion in the year 2027, growing at a CAGR of 9.42% in the period 2020 to 2027. Growth of the market is driven by the prevalence of cerebrovascular diseases and neurovascular disorders, favourable reimbursement policies and expanding healthcare infrastructure.

Neurovascular intervention is an approach for the treatment of neurological disorders and neurovascular diseases that affects the central nervous system. It is also used for the treatment of associated blood vascular systems using minimally invasive procedures. Neurological medical devices have been broadly classified into Neuro-stimulation Devices, Interventional Devices, Cerebral Spinal Fluid (CSF) Management Devices and Neurosurgery Devices.

Technological advancement in the neurovascular intervention industry has brought about a new treatment paradigm for patients suffering from neurovascular diseases. It has led to the deployment of surgical robots for the treatment of strokes. CorPath® GRX System, developed by Corindus, a Siemens Healthineers Company performed the first-in-human robotic-assisted neurovascular intervention in the year 2019.

Report Scope

This report “Global Neurovascular Intervention Market [By Devices - Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) System & Stent Retriever Market; By Application - Stroke, Cerebral Aneurysm, Cerebral Artery Stenosis & Others; By Region- North America (The US), Europe (France & Germany) & Asia Pacific (China & Japan)] Market Outlook 2027” provides detailed analysis of the global neurovascular intervention market from qualitative and quantitative outlooks during the forecast period across various market segments and regional markets. It also provides coverage on market dynamics with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Parameter Description

  • Base year: 2013
  • Forecast period: 2020 - 2027
  • Market sizing: Revenue in US$ Billions and Numbers in Billions & CAGR for the period 2013 to 2027
  • Country coverage: The US, Germany, France, Japan & China
  • Vendor scope: Johnson & Johnson DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc. & Terumo Corporation
  • Report coverage: Revenue forecast, market share analysis, company analysis, competitive landscape, market growth drivers, market restraints, market trends and company profiles

Segments Covered

The report provides revenue forecasts for global, regional and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, the publisher has segmented global neurovascular intervention market report on the basis of geography, devices and application.

Device Outlook, Revenue (2013 - 2027E, US$ Billions)

  • Cerebral Thrombectomy Devices
  • Flow Diverter for Aneurysm
  • Carotid Artery Stenting (CAS) System
  • Stent Retriever Market

Application Outlook, Revenue (2013 - 2027E, US$ Billions)

  • Stroke
  • Cerebral Aneurysm
  • Cerebral Artery Stenosis
  • Others

Regional Outlook, Revenue (2013 - 2027E, US$ Billions)

  • North America
  • Europe
  • Asia Pacific

Country Outlook, Revenue (2013 - 2027E, US$ Billions)

  • The US
  • Germany
  • France
  • Japan
  • China

Vendors Outlook, Revenue (2012 - 2019, US$ Billions)

  • Johnson & Johnson DePuy Synthes
  • Stryker Corporation
  • Medtronic Plc.
  • Penumbra Inc.
  • Terumo Corporation

Target Audience

  • Device Manufacturers
  • Drug Manufacturers
  • End Users
  • Research Professionals
  • Healthcare Consultancies
  • Regulatory Bodies

Key questions answered in the report

  • The historical market size of neurovascular intervention market from 2008 to 2019 in US$ Billions.
  • Projected market growth in the forecasted period 2020 to 2027 with estimated revenue for each year in US$ Billions.
  • Regional and country analysis of neurovascular intervention market is provided for the period 2013 to 2027.
  • Market drivers, restraints and industry trends that have an impact on revenue.
  • Profiling of major companies with a detailed analysis of their neurovascular intervention devices.

Customization

The publisher provides customization of the study in order to provide specific information as sought by the client.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Medtronic Plc
  • Penumbra Inc.
  • Stryker Corporation
  • Terumo Corporation

1. Executive Summary

2. Research Methodology

3. Neurovascular Market
3.1 Neurological Disorders
3.1.1 Overview
3.1.2 Classification
3.1.2.1 Ischemic Strokes
3.1.2.2 Cerebral Aneurysms
3.1.2.3 Cerebral Artery Stenosis
3.1.2.4 Others
3.2 Neurovascular Treatment
3.2.1 Surgical Options
3.2.1.1 Microsurgery
3.2.1.2 Endovascular Surgery
3.2.1.3 Radiosurgery

4. Neurovascular Devices
4.1 Overview
4.2 Classification
4.2.1 Neuro-stimulation Devices
4.2.2 Interventional Devices
4.2.3 Cerebral Spinal Fluid (CSF) Management Devices
4.2.4 Neurosurgery Devices

5. Market Analysis
5.1 Market Sizing (Actual & Forecasted)
5.2 Market Share Analysis
5.2.1 Market Share by Devices
5.2.2 Market Share by Therapeutic Application
5.2.3 Market Share by Region

6. Global Neurovascular Market Segmentation
6.1 By Devices
6.1.1 Cerebral Thrombectomy Devices
6.1.1.1 Overview
6.1.1.2 Market Sizing (Actual & Forecasted)
6.1.1.3 Market Share by Region
6.1.2 Flow Diverter for Aneurysm
6.1.2.1 Overview
6.1.2.2 Market Sizing (Actual & Forecasted)
6.1.2.3 Market Share by Region
6.1.3 Carotid Artery Stenting (CAS) System
6.1.3.1 Overview
6.1.3.2 Market Sizing (Actual & Forecasted)
6.1.3.2 Market Share by Region
6.1.4 Stent Retriever Market
6.1.4.1 Overview
6.1.4.2 Market Sizing (Actual & Forecasted)
6.2 By Application
6.2.1 Stroke
6.2.1.1 Overview
6.2.1.2 Market Sizing (Actual & Forecasted)
6.2.2 Cerebral Aneurysm
6.2.2.1 Overview
6.2.2.2 Market Sizing (Actual & Forecasted)
6.2.3 Cerebral Artery Stenosis
6.2.3.1 Overview
6.2.3.2 Market Sizing (Actual & Forecasted)
6.2.4 Others
6.2.4.1 Overview
6.2.4.2 Market Sizing (Actual & Forecasted)

7. Regional Analysis
7.1 North America
7.1.1 Market Sizing (Actual & Forecasted)
7.1.2 The US
7.1.2.1 Market Sizing (Actual & Forecasted)
7.1.2.2 Market Share by Segment
7.1.2.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
7.1.2.4 Flow Diverter Devices Market Sizing (Actual & Forecasted)
7.1.2.5 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
7.2 Europe
7.2.1 Market Sizing (Actual & Forecasted)
7.2.2 Market Share by Segment
7.2.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
7.2.4 Flow Diverter Devices Market Sizing (Actual & Forecasted)
7.2.5 Germany
7.2.5.1 Market Sizing (Actual & Forecasted)
7.2.6 France
7.2.6.1 Market Sizing (Actual & Forecasted)
7.2.6.2 Market Share by Applications
7.3 Asia Pacific
7.3.1 Market Sizing (Actual & Forecasted)
7.3.2 Market Share by Segment
7.3.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
7.3.4 Japan
7.3.4.1 Market Sizing (Actual & Forecasted)
7.3.5 China
7.3.5.1 Market Sizing (Actual & Forecasted)

8. Global Neurovascular Market Dynamics
8.1 Industry Trends & Developments
8.1.1 Mergers & Acquisitions
8.1.2 Deployment of Surgical Robots
8.1.3 Image-Guided Hi-Def Technology
8.1.4 Other Technological Advancements
8.2 Growth Drivers
8.2.1 Prevalence of Cerebrovascular Diseases
8.2.2 Rising Incidences of Neurological Disorders
8.2.3 Favorable Reimbursement Policies
8.2.4 Expanding Healthcare Infrastructure
8.2.5 Focus on R&D Activities
8.2.6 Rise in Awareness Programs
8.3 Challenges
8.3.1 Stringent Regulatory Policies
8.3.2 High Cost of Treatment
8.3.3 Multiple Product Recalls
8.3.4 Dearth of Skilled Neurosurgeons
8.3.5 Social Stigma

9. Competitive Landscape
9.1 Global
9.2 Regional

10. Company Profiles
10.1 Johnson & Johnson DePuy Synthes
10.2 Stryker Corporation
10.3 Medtronic Plc.
10.4 Penumbra Inc.
10.5 Terumo Corporation

List of Tables and Figures
Figure 1: Research Methodology
Table 1: Description of Neurological Disorders
Table 2: Neurovascular Conditions and Treatment Options
Table 3: Classification of Neurological Medical Devices
Table 4: Major Neurovascular Products
Figure 2: Global Neurovascular Intervention Market Size by Value, 2008-19 (US$ Millions)
Figure 3: Global Neurovascular Intervention Market Size by Value Forecasted, 2020E-27E (US$ Billions)
Figure 4: Global Neurovascular Intervention Market Share by Devices (2020E)
Figure 5: Global Neurovascular Intervention Market Share by Therapeutic Application (2020E)
Figure 6: Global Therapeutic Neurovascular Intervention Device Market Share by Region (2020E)
Table 5: New Generation Cerebral Thrombectomy Devices
Figure 7: Global Cerebral Thrombectomy Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 8: Global Cerebral Thrombectomy Devices Market Share by Region (2020E)
Table 6: Flow Diverter Devices
Figure 9: Global Flow Diverting Aneurysm Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 10: Global Flow Diversion Market Share by Region (2020E)
Figure 11: Global Carotid Artery Stenting (CAS) System Market Size by Value, 2013-27E (US$ Millions)
Figure 12: Global Carotid Artery Stenting (CAS) Systems Devices Market Share by Region (2020E)
Figure 13: Global Neurovascular Stent Retriever Market Size by Value, 2016-27E (US$ Millions)
Figure 14: Global Neurovascular Intervention Application - Stroke Market Size by Value, 2016-27E (US$ Millions)
Figure 15: Global Neurovascular Intervention Application - Cerebral Aneurysm Market Size by Value, 2016-27E (US$ Millions)
Figure 16: Global Neurovascular Intervention Application - Cerebral Artery Stenosis Market Size by Value, 2016-27E (US$ Millions)
Figure 17: Global Neurovascular Intervention Application - Others Market Size by Value, 2016-27E (US$ Millions)
Figure 18: North America Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Figure 19: The US Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Figure 20: The US Neurovascular Intervention Systems Market Share by Segment (2020E)
Figure 21: The US Cerebral Thrombectomy Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 22: The US Flow Diverter Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 23: The US Carotid Artery Stenting (CAS) Systems Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 24: Europe Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Figure 25: Europe Neurovascular Intervention Systems Market Share by Segment (2020E)
Figure 26: Europe Cerebral Thrombectomy Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 27: Europe Flow Diverter Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 28: Germany Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Figure 29: France Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Figure 30: France Neurovascular Intervention Systems Market Share by Application (2020E)
Figure 31: Asia Pacific Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Figure 32: Asia Pacific Neurovascular Intervention Systems Market Share by Segment (2020E)
Figure 33: Asia Pacific Cerebral Thrombectomy Devices Market Size by Value, 2013-27E (US$ Millions)
Figure 34: Japan Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Figure 35: China Neurovascular Intervention Systems Market Size by Value, 2013-27E (US$ Billions)
Table 5: Mergers & Acquisitions in Neurovascular Intervention Market
Figure 36: Global Cerebrovascular Disease Prevalence, 2010-20E (Millions)
Table 6: Number of Disability-Adjusted Life Years (DALYs) for Neurological Disorders and as Percentage of Global DALYs Projected for 2005, 2015 And 2030 (Thousands)
Table 7: Deaths Attributable to Neurological Disorders as a Percentage of Total Deaths, 2005, 2015 And 2030
Figure 37: Global Healthcare Expenditure, 2012-20E (US$ Trillions)
Table 8: Major Neurovascular Companies - Competitive Landscape
Figure 38: Global Neurovascular Intervention Market Share by Competitors (2020E)
Figure 39: Global Carotid Artery Stenting (CAS) Market Share by Competitors (2019)
Figure 40: The US Cerebral Thrombectomy Devices Market Share by Companies (2020E)
Figure 41: The US Stent Retriever Market Share by Companies (2020E)
Figure 42: Europe Stent Retriever Market Share by Companies (2020E)
Figure 43: Johnson & Johnson Revenue by Business Segment (FY2019)
Figure 44: Johnson & Johnson Net Sales, FY2012-FY2019 (US$ Billions)
Figure 45: Stryker Corporation Revenue by Business Segment (FY2019)
Figure 46: Stryker Corporation Net Sales, FY2012-FY2019 (US$ Billions)
Figure 47: Medtronic Plc. Revenue by Business Segment (FY2019)
Figure 48: Medtronic Plc. Net Sales, FY2012-FY2019 (US$ Billions)
Figure 49: Penumbra Inc. Revenue by Business Segment (FY2019)
Figure 50: Penumbra Inc.Net Sales, FY2012-FY2019 (US$ Billions)
Figure 51: Terumo Corporation Revenue by Business Segment (FY2019)
Figure 52: Terumo Corporation Net Sales, FY2012-FY2019 (US$ Billions)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Medtronic Plc
  • Penumbra Inc.
  • Stryker Corporation
  • Terumo Corporation

Neurovascular disorders or diseases refers to abnormality associated with blood vessels supplying blood to the brain and spine. This includes narrowing of arteries, which reduces blood flow to the brain and increases the risk of stroke (particularly “ischemic” stroke), and weakening of arteries, which may create brain aneurysms and increases the risk of intracranial bleeding (or “hemorrhagic” stroke). Neurovascular intervention refers to the diagnosis, treatment, rehabilitation, and prevention of vascular disorders that affect the central nervous system using minimally invasive technologies or procedures. The ischemic stroke segment is addressed by technologies such as angioplasty and stenting of narrowed cerebral arteries. Flow-diverters are a notable new option for treatment of the cerebral aneurysm.

Neurovascular intervention market is expected to witness meteoric growth over the forecast period. Growth of the market is driven by the prevalence of cerebrovascular diseases, rising incidence of neurological disorders, favourable reimbursement policies, expanding healthcare infrastructure, focus on R&D activities and rise in awareness programs. However, the market faces several challenges due to stringent regulatory policies, high cost of treatment, multiple products recalls, the dearth of skilled neurosurgeons and social stigma.

The report “Global Neurovascular Intervention Market [By Devices - Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) System & Stent Retriever Market; By Application - Stroke, Cerebral Aneurysm, Cerebral Artery Stenosis & Others; By Region- North America (The US), Europe (France & Germany) & Asia Pacific (China & Japan)] Market Outlook 2027” provides an in-depth analysis of the current scenario, detailed market outlook of the global neurovascular intervention market. The market is segmented by device type and application areas. Future forecasts of neurovascular intervention market overall and across various regional markets have been provided in the report till 2027. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global neurovascular intervention market include Johnson & Johnson DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc. & Terumo Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global neurovascular intervention market.

Note: Product cover images may vary from those shown
  • Corindus, a Siemens Healthineers Company
  • Johnson & Johnson DePuy Synthes
  • Medtronic Plc
  • Penumbra Inc.
  • Stryker Corporation
  • Terumo Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll